Advertisement

Digestive Disease Week, June 2-5

0
Digestive Disease Week 2018 The Digestive Disease Week annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological...
Compared to saphenous-vein grafts

Radial-Artery Grafts Better Than Saphenous-Vein Grafts in CABG

0
Lower adverse cardiac events seen at five-year follow-up after coronary-artery bypass surgery
The prevalence of being uninsured varies by occupational groups

CDC: Prevalence of No Insurance Varies by Occupational Groups

0
Significant drop in prevalence of uninsured from 2013 to 2014; variation by occupation in both years
Post-transplant hepatitis C treatment increases access to transplant and reduces waitlist time among hepatitis C-positive patients awaiting kidney transplantation

Post-Transplant Tx Reduces Wait for Kidney in Hep C+ Patients

0
Delaying treatment until after transplant doesn't adversely impact kidney allograft or survival
Online physician reviews tend to be skewed positively

Online Consumer Ratings of Physicians Tend to Be Skewed

0
Ratings also differ significantly by specialty group
The actual number of deaths related to Hurricane Maria in Puerto Rico in 2016 is likely more than 70 times the official government estimate of 64

Post-Hurricane Deaths in Puerto Rico Underestimated

0
New estimate puts hurricane-related deaths at 4,645; many attributed to delayed, interrupted health care
Liposomal bupivacaine use in patients undergoing total knee arthroplasty is not associated with clinically meaningful reductions in inpatient opioid use

Benefit of Liposomal Bupivacaine for Pain in TKA Questioned

0
No clinically relevant reduction in inpatient opioid use, costs for patients undergoing total knee arthroplasty
A considerable proportion of breast cancer survivors do not undergo annual surveillance breast imaging

Many Breast Cancer Survivors Do Not Undergo Annual Surveillance

0
In year 1, 13 percent did not undergo MRI or mammography; up to 19 percent by year 5
For patients with metastatic renal cell carcinoma classified as having intermediate or poor prognostic risk

ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer

0
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
The oxaliplatin

ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer

0
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery